|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online January 11, 2008
doi: 10.1242/10.1242/dev.012377
Department of Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
* Author for correspondence (e-mail: talbot{at}cmgm.stanford.edu)
Accepted 12 November 2007
| SUMMARY |
|---|
|
|
|---|
Key words: Kif1-binding protein, Axonal outgrowth, Mental retardation, Neurodegeneration, Zebrafish
| INTRODUCTION |
|---|
|
|
|---|
The Stathmin family of phospho-proteins is one of a small number that have
been shown to interact with and regulate the dynamics of microtubules
(Grenningloh et al., 2004
).
Stathmin itself can destabilize microtubules
(Belmont and Mitchison, 1996
),
whereas another family member, SCG10, can stabilize microtubules at their plus
ends and destabilize them at their minus ends
(Manna et al., 2007
).
Structural microtubule associated proteins (MAPs) can also regulate
microtubule dynamics (Baas and Qiang,
2005
). Overexpression of the most prominent axonal MAP, tau,
compromises the ability of kinesin motor proteins to bind to microtubules
(Mandelkow et al., 2003
;
Stamer et al., 2002
), causing
a cascade of events that can lead to the severing of microtubules themselves
(Baas and Qiang, 2005
;
Qiang et al., 2006
;
Yu et al., 2005
). Increasing
data suggest that defects in microtubule based axonal transport may cause
neural degeneration that is symptomatic of many human neurological disorders,
including Alzheimer's disease, Parkinson's disease and amyotrophic lateral
sclerosis (ALS) (Duncan and Goldstein,
2006
). Indeed, the protein products of genes linked to Alzheimer's
disease, Parkinson's disease and ALS are all transported along the axon and
their mislocalization may even contribute to disease symptoms
(Duncan and Goldstein, 2006
).
These data highlight the importance of microtubule organization and of
microtubule based axonal transport during axonal maintenance and disease.
Although genetic and biochemical approaches have provided great insight
into the function of kinesin superfamily (Kif) motor proteins during neuronal
development and disease (Hirokawa and
Takemura, 2005
), we are only beginning to understand the function
of additional factors that affect their regulation. Biochemical
characterization of a novel factor called Kif1-binding protein (KBP) showed
that it can bind to the motor domain of the related kinesin motor proteins
Kif1B and Kif1C, and in vitro analyses suggested that it may regulate motor
protein motility on microtubules (Wozniak
et al., 2005
). However, further biochemical characterization of
this factor is limited, and it is possible that KBP could bind to other
related kinesins or indeed to unrelated molecules. Interestingly, homozygous
mutations of KBP, also known as KIAA1279, cause a rare but severe neurological
disorder, Goldberg-Shprintzen syndrome (GSS), in humans
(Brooks et al., 2005
). GSS is
characterized primarily by neurological symptoms, including mental retardation
and disruption to white matter tracts
(Fryer, 1998
;
Goldberg and Shprintzen, 1981
;
Murphy et al., 2006
;
Silengo et al., 2003
;
Tanaka et al., 1993
;
Yomo et al., 1991
). Very
little is known about the cellular basis of GSS and in the absence of an
animal model that disrupts KBP activity, elucidation of its function during
neural development and disease has remained limited.
Here, we present the characterization of a zebrafish kinesin kbp mutant. We show that kbp mutant axons grow at reduced speeds and that many axons undergo degeneration at later stages. Ultrastructural analyses demonstrate disruption to axonal microtubules at early stages and further disruption to microtubules and mislocalization of axonal mitochondria at later stages. Based on these data, we propose that KBP is an important regulator of the axonal cytoskeleton that affects the speed of axonal outgrowth and the maintenance of axons. These data provide insight into the function of KBP during neural development and support the growing body of evidence that disruption to the axonal cytoskeleton can contribute to human disease.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Positional cloning and molecular analyses of kbp
The st23 mutation was mapped by bulked segregant analyses with
SSLPs by standard methods (Talbot and
Schier, 1999
). Initial mapping placed the st23 mutation
between markers z47593 (one recombinant out of 688 meioses) and z67865
(42/688) on linkage group 13. To generate additional markers for
high-resolution mapping, we consulted the zebrafish genome assembly. Among the
markers that failed to recombine with the mutation was one associated with the
zebrafish ortholog of kbp. We sequenced the kbp gene from
wild-type genomic DNA, confirming the gene structure predicted by the Sanger
Institute. Sequencing of mutant genomic DNA identified a GT to AT mutation
that disrupted the splice donor at the beginning of intron 5. The full-length
kbp coding sequence was submitted to GenBank (Accession number
EU234534).
To determine whether kbp mRNA was present in kbpst23 mutants, RNA was extracted from larvae at 7 days post fertilization (dpf), which were sorted from a kbpst23/+, Tg(Foxd3:gfp) intercross. For some experiments, RNA was extracted from individual genotyped (see below) embryos. RT-PCR was carried out on cDNA with primers flanking the lesion site, one in exon 5, 5'-ATGGAGGCTCGTCATTGTTT-3' and one in exon 6, 5'-GCATCTTGCAACAAATTAAGG-3'. RT-PCRs were carried out with a 2.5-minute extension for 44 cycles. RT-PCR was also carried out using primers spanning exons 4-6, one in exon 4, 5'-CGCACACGCTGTATTACCTG-3' and one in exon 6, 5'-GATCCAGCATCTGGCAATTT-3'. These RT-PCRs were carried out with a 1-minute extension for 30 cycles.
Genotyping
Two DCAPS assays were used to score for the kbpst23
mutation. PCR was carried out with 5'-CTCAGAGGCAGCTGCCAAACTAA-3'
and 5'-ACGACACTGTTTCAGAAGAA-3', and PCR products digested with the
restriction enzyme DdeI, yielding a smaller fragment from the
wild-type allele. In more recent experiments, PCR was carried out with a
second set of primers, 5'-AAAACGACCAACTGTGCCTA-3' and
5'-ACAGTCAAACACCAGATCGAAAGTCA-3' and digested with
MaeIII, yielding a smaller fragment from the wild-type allele.
kbp morpholino
Embryos were injected at the one-cell stage with 2.4 ng of a morpholino
antisense oligonucleotide spanning the end of exon 1 and the beginning of
intron 1 of zebrafish kbp
(5'-GTTAGTGTGTATTTACCCGGACATG-3'), obtained from Gene Tools.
In situ hybridization
To synthesize kbp riboprobes, a 1815 bp region covering exons 1-7
was PCR amplified from cDNA made from zebrafish at 72 hours post-fertilization
(hpf), with the following primers: F, 5'-TGGCTGCCAACACAGTATCG-3'
and R, 5'-GCTCGGTTTCTACAGCGTTC-3'. The PCR product was cloned into
pCR II-TOPO vector (Invitrogen) and sequenced. This construct was linearized
by XbaI and transcribed with SP6 for antisense and linearized with
BamHI and transcribed with T7 for sense.
Immunohistochemistry
Anti-acetylated tubulin (Sigma) was used at a dilution of 1:1000,
anti-HuC/D (Molecular probes) at 1:500 and secondary antibodies conjugated to
either Alexa488 or Alexa568 (Molecular probes) at 1:2000. Images were taken on
a Zeiss LSM confocal microscope.
Transplantation
To generate chimeric embryos, we transplanted cells at the blastula stage
from wild-type donor embryos labeled with 1% Texas Red dextran (Molecular
Probes) into kbpst23 mutant hosts. Live chimeras were
imaged at 80 hpf, and genotypes were determined by PCR as described above.
Time-lapse microscopy and analyses
Embryos were imbedded in 1.5% low melting point agarose in embryo medium
with Tricaine and imaged on a Zeiss LSM confocal microscope. All time-lapse
recordings were carried out at 28.5°C with an interval of 5 minutes.
Analyses of time-lapse data were carried out using ImageJ.
Axonal mitochondrial and synaptic vesicle protein labeling
To co-label axons and mitochondria single cells were injected with 1%
Oregon Green Dextran (Molecular Probes) and 200 ng/µl mito:mCherry mRNA at
the 32-256 cell stage. Embryos were screened at 48 hpf and those with labeled
PLL or reticulospinal neurons were selected and imaged.
To co-label axons and synaptophysin, embryos were injected at the one cell
stage with 25 pg of syn:GFP-DSR plasmid DNA
(Meyer and Smith, 2006
).
Embryos were screened at 96 hpf and those with suitably labeled neurons were
imaged.
Cartilage staining
Alcian Blue (0.1% in 0.37% HCl, 70% ethanol) was used to label cartilage
according to standard protocols (Schilling
et al., 1996
).
Transmission electron microscopy
Embryos were fixed for TEM in modified Karnovsky's solution (2%
glutaraldehyde + 4% paraformaldehyde in 0.1 M sodium cacodylate buffer), post
fixed in 2% osmium tetroxide in 0.1 M imidazole and 0.1 M sodium cacodylate,
stained en bloc in saturated uranyl acetate, and dehydrated into 100% acetone.
All of these steps were accelerated by a microwave stimulation regime using
the PELCO 3470 Multirange Laboratory Microwave System (Pelco) and kept at
15°C in a cooled water bath using the PELCO Steady Temp throughout.
Following dehydration, embryos were embedded in Epon, and stained and imaged
as described previously (Pogoda et al.,
2006
).
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
KBP is required autonomously in neurons for axonal outgrowth
To test whether KBP was required cell autonomously in neurons for normal
axonal development, we created genetic chimeras by transplanting fluorescently
labeled wild-type cells into kbpst23 mutant animals at
blastula stages. In five such chimeras, at 80 hpf, we saw wild-type
reticulospinal neurons with axons that extended down the entire length of the
spinal cord (Fig. 4B,B').
In two additional cases, we saw wild-type PLL neurons with axons that extended
along the entire length of the lateral line
(Fig. 4A,A'). We have
never seen reticulospinal or PLL neurons with axons that extend along the
entire length of their respective tissues in the kbpst23
mutant. These data show that kbp is required autonomously in neurons
for axonal outgrowth.
|
kbp is required for axonal maintenance
Axons of the kbpst23 mutant PLLn are typically
truncated at the level of somites 6-10 by 5 dpf, but many grow significantly
further than this at earlier stages. We performed additional time-lapse
experiments between 2 and 3 dpf to look for evidence of axonal degeneration or
retraction. We observed net backwards movement of axons in
kbpst23 mutants and noted the periodic formation and
backwards movement of punctate axonal swellings in the
kbpst23 mutant PLLn
(Fig. 5D-D'' and Movie 3
in the supplementary material). We did not observe axonal swellings such as
those in wild type. Axonal swellings are commonly associated with axonal
degeneration (Coleman, 2005
).
Furthermore, we noticed that the PLLn became thinner over time and
occasionally noticed fragmentation of axons, also indicative of degeneration.
These data suggest that kbpst23 mutant axons degenerate
and that kbp is required for the longer-term maintenance of axons in
addition to outgrowth.
As previous studies have suggested that KBP may associate with mitochondria
(Wozniak et al., 2005
) we
assessed whether mitochondrial localization was disrupted in
kbpst23 mutant axons. We saw a reduction in the intensity
of mito:mCherry labeling in individual kbpst23 mutant
axons compared with wild type, (Fig.
6A-D), but the small size of axonal mitochondria precluded
quantitative analysis of mitochondrial distribution and dynamics at the light
microscopy level. We did not see any overt defects in the localization of the
synaptic vesicle protein marker, synaptophysin:GFP
(Meyer and Smith, 2006
) in
kbpst23 mutant axons
(Fig. 6E,F).
kbp is required for microtubule organization and the localization of axonal cargo
To better understand the cellular basis of kbpst23
mutant axonal defects, we examined their ultrastructure by transmission
electron microscopy (TEM). Close examination of kbpst23
mutant axons in the PLLn during early stages of outgrowth revealed
disorganization of axonal microtubules: in the wild type at 30 hpf, most
microtubules are oriented along the long axis of the axon, whereas the
microtubules are present in many different orientations in
kbpst23 mutant axons
(Fig. 7A,B). We did not observe
any differences in the number of axonal mitochondria between wild type and
kbpst23 mutants at these early stages, suggesting that the
primary defect in kbpst23 mutants is disorganization of
the axonal cytoskeleton. Examination at later stages demonstrated a decrease
in axon number in the kbpst23 mutant PLLn and dark axonal
discoloration (Fig. 7E,F), both
of which provide additional evidence of axonal degeneration. In addition, we
saw continued disruption to axonal microtubules
(Fig. 7C,D) and now also a
clear reduction in the number of mitochondria within axons
(Fig. 7E,F). At 50 hpf, at
somite levels 1, 6 and 12 we counted an average of 64, 48 and 32 axons in the
wild-type PLLn, compared with 40, 26 and 7 in the kbpst23
mutant. Of these 24, 27 and 17% contained a mitochondrion in wild type,
compared with 11, 12 and 9% in the kbpst23 mutant.
|
|
Ultrastructural examination of reticulospinal neurons at 30 hpf proved
difficult as these axons do not have distinct morphological features that
allow their unambiguous identification among the many other axons in the
spinal cord. By 50 hpf, however, we documented a marked reduction in the
number of large diameter reticulospinal axons in the ventral spinal cord of
kbpst23 mutants (Fig.
8A,B). We counted an average of 20±2 axons with a diameter
greater than 0.75 µm in wild-type animals, compared with an average of only
9±1 axons of that size in the kbpst23 mutant. As in
the PNS, in the wild-type CNS most microtubules are oriented along the long
axis of the axon, whereas the microtubules are present in many different
orientations in large diameter kbpst23 mutant axons
(Fig. 8A-D). By 72 hpf, we saw
further defects in the kbpst23 mutant CNS. The number of
large-diameter axons was still reduced (WT average of 32±1 axons larger
than 0.75 µm compared with 15±4 in the kbpst23
mutant), and most of those that were present in the mutant remained
unmyelinated (Fig. 8E,F). In
the wild type, more than two-thirds (22 of 32) of axons of greater than 0.75
µm were myelinated, compared with only 40% (6 out of 15) in the
kbpst23 mutant. As at earlier stages, disorganization of
the axonal cytoskeleton was also evident at 72 hpf
(Fig. 8E,F). In addition, we
saw swollen vacuolated mitochondria in kbp mutant axons in the CNS
and a dark discoloration of some axons, also providing evidence of axonal
degeneration in the CNS (McHale et al.,
1995
). At later stages, we continued to note a reduction in the
number of large-diameter axons and hypomyelination in the
kbpst23 mutant (Fig.
8G-I). These data indicate that kbp is required for
organization of axonal microtubules, and axonal outgrowth and maintenance in
the CNS.
kbp is required for axonal development in the enteric nervous system
Histological examination of individuals with GSS has documented variable
degrees of aganglionic megacolon, i.e. loss of enteric neurons
(Brooks et al., 1999
;
Murphy et al., 2006
;
Ohnuma et al., 1997
;
Silengo et al., 2003
).
Analysis of the neuronal marker HuC/D showed that overt neuronal
differentiation is normal in the kbpst23 mutant ENS until
at least 10 dpf (Fig. 9A,B).
Examination of the ultrastructure of the enteric nervous system in the
kbpst23 mutant, however, showed that
kbpst23 mutants have a greatly reduced number of axons in
the ENS at 7 dpf (wild-type average of 218±42 compared with
kbpst23 average of 97±15). Many of those axons
present in the kbpst23 mutant ENS had disorganized
microtubules and abnormal accumulations of axonal synaptic vesicles
(Fig. 9C,D). These data show
that kbp is important for axonal development in the ENS in addition
to the PNS and CNS, but that the early differentiation of neural crest-derived
neurons is normal. Whereas individuals with GSS also develop craniofacial
abnormalities, early development of craniofacial cartilages and other
derivatives of the neural crest, such as pigment cells and Schwann cell
precursors, are also normal in kbpst23 mutants
(Fig. 9E,F;
Fig. 1C,D)
(Pogoda et al., 2006
).
|
| DISCUSSION |
|---|
|
|
|---|
|
is one of two prominent nervous system isoforms of Kif1B and is
thought to bind to mitochondria (Nangaku
et al., 1994
(Wozniak et al., 2005
(Wozniak et al.,
2005
Disruption of mitochondrial transport and function has been associated with
axonal degeneration (Coleman,
2005
), a phenotype characteristic of kbp mutants.
Blockade of mitochondrial transport is likely to decrease available ATP in the
axon distal to the disruption of transport. This disrupts the function of the
Na+ K+ ATPase, which causes a cascade of events that
leads to an influx of Na+ and Ca2+ ions into the axon
and the subsequent activation of enzymes that lead to the degradation of the
cytoskeleton, the formation of axonal swellings and ultimately axonal
degeneration (Coleman, 2005
).
We frequently observed swollen mitochondria in mutant axons, particularly in
the CNS, suggesting that it is possible that mitochondrial dysfunction leads
to degeneration in the kbp mutant.
It is not clear, however, how a KBP-Kif1B mitochondrion-related function
might regulate axonal outgrowth in vivo. Indeed, it has been shown that the
main isoform of Kif1B that is expressed in the brain lacks the
mitochondrial-binding domain (Conforti et
al., 1999
) and Kif1B mutant mice do not have defects in
mitochondrial transport in axons (Zhao et
al., 2001
), suggesting that the role of Kif1B in regulating
mitochondrial transport might be limited or fulfilled by another kinesin, such
as Kif5B (Tanaka et al.,
1998
). Because KBP binds to the motor domain of Kif1B and Kif1C,
and the motor domains of kinesin proteins are similar, it is possible that KBP
is essential for the activity of yet other kinesins and thus the transport of
other cargo.
KBP, microtubule organization and axonal development
Our analyses demonstrate that KBP has a key role in the regulation of
microtubule organization. It is possible that the primary defect in
kbp mutants is disorganization of microtubules, which would in turn
cause secondary disruptions in the localization of axonal constituents.
Supporting this possibility, disruption to microtubules is the first phenotype
that we observed in our ultrastructural analyses of the kbp mutants.
Similar disruptions in microtubules have not been described in mammalian
kif1 mutants, raising the possibility that KBP regulates microtubule
dynamics independent of Kif1 kinesins. Axonal microtubules are regulated at
many levels, and any of these could potentially involve KBP. For example,
stathmin controls the availability of soluble tubulin molecules
(Fletcher and Rorth, 2007
); the
tubulin specific chaperone e (tbce) ensures proper folding of
-tubulin
and regulates tubulin heterodimer formation
(Kortazar et al., 2007
); SCG10
regulates the dynamics of microtubules in growing axons
(Belmont and Mitchison, 1996
;
Riederer et al., 1997
;
Suh et al., 2004
); and
microtubule-associated proteins (MAPs), such as tau, have a number of
important functions. In fact, tbce mutant mice have a somewhat
similar phenotype to our kbp mutant, with disruption to axonal
microtubules and subsequent axonal degeneration
(Martin et al., 2002
). Further
biochemical studies will be required to elucidate the mechanisms by which KBP
regulates the axonal cytoskeleton.
KBP and symptoms of GSS
Mutation of KBP (KIAA1279) causes Goldberg-Shprintzen syndrome in humans
(Brooks et al., 2005
). Though
rare, GSS has very severe symptoms, for which there are currently no
treatments. One of the most consistent features of this syndrome is disruption
to white matter tracts (Ohnuma et al.,
1997
; Silengo et al.,
2003
). We believe that the zebrafish kbpst23
mutation provides a good model of these defects in myelinated axons. We
suggest that the cellular basis of these myelinated axon symptoms in GSS is
disruption to axonal microtubules. Our results also demonstrated that axons in
the kbp mutant ENS are disrupted, suggesting that axonal
abnormalities in the ENS may reveal a novel mechanism by which Hirschsprung's
disease-like symptoms can emerge. Hirschsprung's is typically thought to be
caused by defects in neural crest development
(Amiel et al., 2000
), whereas
the first defects in the ENS of the kbpst23 mutant arise
in differentiated neurons. Although we did not see an obvious reduction in the
number of ENS neurons at the stages examined, it is possible that neurons are
lost later, as a secondary consequence of initial disruption to axons. Indeed,
in a mammalian model of Alzheimer's disease, disruption to axons was observed
up to a year before the more commonly recognized disease-related neuronal
pathology (Stokin et al.,
2005
).
Further analyses of our zebrafish kbp mutant may provide a basis
to pursue and evaluate potential therapies for Goldberg-Shprintzen syndrome
and axonal degeneration. The zebrafish is emerging as an ideal system in which
to carry out drug discovery screens in vivo
(Murphey and Zon, 2006
;
Peterson et al., 2004
;
North et al., 2007
).
Identification of compounds that affect KBP activity may provide mechanistic
insight into its function that may not be easily derived from other
approaches.
Conclusions
Our analysis demonstrates that kbp is required to organize the
axonal cytoskeleton, regulate the speed of axonal outgrowth, localize axonal
cargo and maintain the longer-term integrity of axons. These data show that
kbp is required for multiple stages of axonal development and provide
the first animal model of symptoms of Goldberg-Shprintzen syndrome.
Supplementary material
Supplementary material for this article is available at
http://dev.biologists.org/cgi/content/full/135/3/599/DC1
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
Amiel, J., Salomon, R., Attie-Bitach, T., Touraine, R., Steffann, J., Pelet, A., Nihoul-Fekete, C., Vekemans, M., Munnich, A. and Lyonnet, S. (2000). [Molecular genetics of Hirschsprung disease: a model of multigenic neurocristopathy]. J. Soc. Biol. 194,125 -128.[Medline]
Baas, P. W. and Qiang, L. (2005). Neuronal microtubules: when the MAP is the roadblock. Trends Cell Biol. 15,183 -187.[CrossRef][Medline]
Belmont, L. D. and Mitchison, T. J. (1996). Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 84,623 -631.[CrossRef][Medline]
Brooks, A. S., Breuning, M. H., Osinga, J., vd Smagt, J. J.,
Catsman, C. E., Buys, C. H., Meijers, C. and Hofstra, R. M.
(1999). A consanguineous family with Hirschsprung disease,
microcephaly, and mental retardation (Goldberg-Shprintzen syndrome).
J. Med. Genet. 36,485
-489.
Brooks, A. S., Bertoli-Avella, A. M., Burzynski, G. M., Breedveld, G. J., Osinga, J., Boven, L. G., Hurst, J. A., Mancini, G. M., Lequin, M. H., de Coo, R. F. et al. (2005). Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems. Am. J. Hum. Genet. 77,120 -126.[CrossRef][Medline]
Coleman, M. (2005). Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 6,889 -898.[CrossRef][Medline]
Conforti, L., Buckmaster, E. A., Tarlton, A., Brown, M. C., Lyon, M. F., Perry, V. H. and Coleman, M. P. (1999). The major brain isoform of kif1b lacks the putative mitochondria-binding domain. Mamm. Genome 10,617 -622.[CrossRef][Medline]
Duncan, J. E. and Goldstein, L. S. (2006). The genetics of axonal transport and axonal transport disorders. PLoS Genet. 2,e124 .[CrossRef][Medline]
Fletcher, G. and Rorth, P. (2007). Drosophila stathmin is required to maintain tubulin pools. Curr. Biol. 17,1067 -1071.[CrossRef][Medline]
Fryer, A. E. (1998). Goldberg-Shprintzen syndrome: report of a new family and review of the literature. Clin. Dysmorphol. 7,97 -101.[CrossRef][Medline]
Gilmour, D. T., Maischein, H. M. and Nusslein-Volhard, C. (2002). Migration and function of a glial subtype in the vertebrate peripheral nervous system. Neuron 34,577 -588.[CrossRef][Medline]
Goldberg, R. B. and Shprintzen, R. J. (1981). Hirschsprung megacolon and cleft palate in two sibs. J. Craniofac. Genet. Dev. Biol. 1,185 -189.[Medline]
Gordon-Weeks, P. R. (2004). Microtubules and growth cone function. J. Neurobiol. 58, 70-83.[CrossRef][Medline]
Grenningloh, G., Soehrman, S., Bondallaz, P., Ruchti, E. and Cadas, H. (2004). Role of the microtubule destabilizing proteins SCG10 and stathmin in neuronal growth. J. Neurobiol. 58,60 -69.[CrossRef][Medline]
Hirokawa, N. and Takemura, R. (2005). Molecular motors and mechanisms of directional transport in neurons. Nat. Rev. Neurosci. 6,201 -214.[CrossRef][Medline]
Jontes, J. D., Buchanan, J. and Smith, S. J. (2000). Growth cone and dendrite dynamics in zebrafish embryos: early events in synaptogenesis imaged in vivo. Nat. Neurosci. 3,231 -237.[CrossRef][Medline]
Kortazar, D., Fanarraga, M. L., Carranza, G., Bellido, J., Villegas, J. C., Avila, J. and Zabala, J. C. (2007). Role of cofactors B (TBCB) and E (TBCE) in tubulin heterodimer dissociation. Exp. Cell Res. 313,425 -436.[CrossRef][Medline]
Mandelkow, E. M., Stamer, K., Vogel, R., Thies, E. and Mandelkow, E. (2003). Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol. Aging 24,1079 -1085.[CrossRef][Medline]
Maness, P. F. and Schachner, M. (2007). Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat. Neurosci. 10,19 -26.[CrossRef][Medline]
Manna, T., Grenningloh, G., Miller, H. P. and Wilson, L. (2007). Stathmin family protein SCG10 differentially regulates the plus and minus end dynamics of microtubules at steady state in vitro: implications for its role in neurite outgrowth. Biochemistry 46,3543 -3552.[CrossRef][Medline]
Martin, N., Jaubert, J., Gounon, P., Salido, E., Haase, G., Szatanik, M. and Guenet, J. L. (2002). A missense mutation in Tbce causes progressive motor neuronopathy in mice. Nat. Genet. 32,443 -447.[CrossRef][Medline]
McHale, M. K., Hall, G. F. and Cohen, M. J. (1995). Early cytoskeletal changes following injury of giant spinal axons in the lamprey. J. Comp. Neurol. 353, 25-37.[CrossRef][Medline]
Meyer, M. P. and Smith, S. J. (2006). Evidence
from in vivo imaging that synaptogenesis guides the growth and branching of
axonal arbors by two distinct mechanisms. J. Neurosci.
26,3604
-3614.
Murphey, R. D. and Zon, L. I. (2006). Small molecule screening in the zebrafish. Methods 39,255 -261.[CrossRef][Medline]
Murphy, H. R., Carver, M. J., Brooks, A. S., Kenny, S. E. and Ellis, I. H. (2006). Two brothers with Goldberg-Shprintzen syndrome. Clin. Dysmorphol. 15,165 -169.[CrossRef][Medline]
Nangaku, M., Sato-Yoshitake, R., Okada, Y., Noda, Y., Takemura, R., Yamazaki, H. and Hirokawa, N. (1994). KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79,1209 -1220.[CrossRef][Medline]
North, T. E., Goessling, W., Walkley, C. R., Lengerke, C., Kopani, K. R., Lord, A. M., Weber, G. J., Bowman, T. V., Jang, I. H., Grosser, T. et al. (2007). Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447,1007 -1011.[CrossRef][Medline]
Ohnuma, K., Imaizumi, K., Masuno, M., Nakamura, M. and Kuroki, Y. (1997). Magnetic resonance imaging abnormalities of the brain in Goldberg-Shprintzen syndrome (Hirschsprung disease, microcephaly, and iris coloboma). Am. J. Med. Genet. 73,230 -232.[CrossRef][Medline]
Peterson, R. T., Shaw, S. Y., Peterson, T. A., Milan, D. J., Zhong, T. P., Schreiber, S. L., MacRae, C. A. and Fishman, M. C. (2004). Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat. Biotechnol. 22,595 -599.[CrossRef][Medline]
Pogoda, H. M., Sternheim, N., Lyons, D. A., Diamond, B., Hawkins, T. A., Woods, I. G., Bhatt, D. H., Franzini-Armstrong, C., Dominguez, C., Arana, N. et al. (2006). A genetic screen identifies genes essential for development of myelinated axons in zebrafish. Dev. Biol. 298,118 -131.[CrossRef][Medline]
Polleux, F., Ince-Dunn, G. and Ghosh, A. (2007). Transcriptional regulation of vertebrate axon guidance and synapse formation. Nat. Rev. Neurosci. 8, 331-340.[Medline]
Qiang, L., Yu, W., Andreadis, A., Luo, M. and Baas, P. W.
(2006). Tau protects microtubules in the axon from severing by
katanin. J. Neurosci.
26,3120
-3129.
Riederer, B. M., Pellier, V., Antonsson, B., Di Paolo, G.,
Stimpson, S. A., Lutjens, R., Catsicas, S. and Grenningloh, G.
(1997). Regulation of microtubule dynamics by the neuronal
growth-associated protein SCG10. Proc. Natl. Acad. Sci.
USA 94,741
-745.
Sato, T., Takahoko, M. and Okamoto, H. (2006). HuC:Kaede, a useful tool to label neural morphologies in networks in vivo. Genesis 44,136 -142.[CrossRef][Medline]
Schilling, T. F., Piotrowski, T., Grandel, H., Brand, M., Heisenberg, C. P., Jiang, Y. J., Beuchle, D., Hammerschmidt, M., Kane, D. A., Mullins, M. C. et al. (1996). Jaw and branchial arch mutants in zebrafish I: branchial arches. Development 123,329 -344.[Abstract]
Silengo, M., Ferrero, G. B., Tornetta, L., Cortese, M. G., Canavese, F., D'Alonzo, G. and Papalia, F. (2003). Pachygyria and cerebellar hypoplasia in Goldberg-Shprintzen syndrome. Am. J. Med. Genet. A 118,388 -390.[Medline]
Stamer, K., Vogel, R., Thies, E., Mandelkow, E. and Mandelkow,
E. M. (2002). Tau blocks traffic of organelles,
neurofilaments, and APP vesicles in neurons and enhances oxidative stress.
J. Cell Biol. 156,1051
-1063.
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G.,
Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams,
D. S. et al. (2005). Axonopathy and transport deficits early
in the pathogenesis of Alzheimer's disease. Science
307,1282
-1288.
Suh, L. H., Oster, S. F., Soehrman, S. S., Grenningloh, G. and
Sretavan, D. W. (2004). L1/Laminin modulation of growth cone
response to EphB triggers growth pauses and regulates the microtubule
destabilizing protein SCG10. J. Neurosci.
24,1976
-1986.
Talbot, W. S. and Schier, A. F. (1999). Positional cloning of mutated zebrafish genes. Methods Cell Biol. 60,259 -286.[Medline]
Tanaka, H., Ito, J., Cho, K. and Mikawa, M. (1993). Hirschsprung disease, unusual face, mental retardation, epilepsy, and congenital heart disease: Goldberg-Shprintzen syndrome. Pediatr. Neurol. 9,479 -481.[CrossRef][Medline]
Tanaka, Y., Kanai, Y., Okada, Y., Nonaka, S., Takeda, S., Harada, A. and Hirokawa, N. (1998). Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria. Cell 93,1147 -1158.[CrossRef][Medline]
Wozniak, M. J., Melzer, M., Dorner, C., Haring, H. U. and Lammers, R. (2005). The novel protein KBP regulates mitochondria localization by interaction with a kinesin-like protein. BMC Cell Biol. 6,35 .[CrossRef][Medline]
Yomo, A., Taira, T. and Kondo, I. (1991). Goldberg-Shprintzen syndrome: Hirschsprung disease, hypotonia, and ptosis in sibs. Am. J. Med. Genet. 41,188 -191.[CrossRef][Medline]
Yu, W., Solowska, J. M., Qiang, L., Karabay, A., Baird, D. and
Baas, P. W. (2005). Regulation of microtubule severing by
katanin subunits during neuronal development. J.
Neurosci. 25,5573
-5583.
Zhao, C., Takita, J., Tanaka, Y., Setou, M., Nakagawa, T., Takeda, S., Yang, H. W., Terada, S., Nakata, T., Takei, Y. et al. (2001). Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105,587 -597.[CrossRef][Medline]
Zou, Y. and Lyuksyutova, A. I. (2007). Morphogens as conserved axon guidance cues. Curr. Opin. Neurobiol. 17,22 -28.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
P. W. Ingham The power of the zebrafish for disease analysis Hum. Mol. Genet., April 15, 2009; 18(R1): R107 - R112. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||